Keros Therapeutics Appoints Dr. Anne Prener to Board
Keros Therapeutics announced the appointment of Anne Prener to its board of directors. This leadership change is expected to strengthen the company's clinical expertise as it continues advancing its therapy pipeline.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day